Cargando…
A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support
Hematopoietic stem cell transplantation following myeloablative chemotherapy is a curative treatment for many hematopoietic malignancies. However, profound granulocytopenia during the interval between transplantation and marrow recovery exposes recipients to risks of fatal infection, a significant s...
Autores principales: | Desai, Amar, Zhang, Yongyou, Park, Youngsoo, Dawson, Dawn M., Larusch, Gretchen A., Kasturi, Lakshmi, Wald, David, Ready, Joseph M., Gerson, Stanton L., Markowitz, Sanford D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058768/ https://www.ncbi.nlm.nih.gov/pubmed/29472361 http://dx.doi.org/10.3324/haematol.2017.178376 |
Ejemplares similares
-
15-PGDH regulates hematopoietic and gastrointestinal fitness during aging
por: Ho, Won Jin, et al.
Publicado: (2022) -
15-PGDH inhibition activates the splenic niche to promote hematopoietic regeneration
por: Smith, Julianne N.P., et al.
Publicado: (2021) -
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
por: Smith, Julianne N. P., et al.
Publicado: (2020) -
Polymer Microparticles Prolong Delivery of the 15-PGDH Inhibitor SW033291
por: Dogan, Alan B., et al.
Publicado: (2021) -
Small molecule inhibitors of 15-PGDH exploit a physiologic induced-fit closing system
por: Huang, Wei, et al.
Publicado: (2023)